Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.011 SGD | 0.00% | 0.00% | +10.00% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 11.22 | 11.22 | 8.605 | 24.67 | 13.02 | 10.31 |
Enterprise Value (EV) 1 | 18.21 | 19.21 | 12.58 | 22.98 | 17.26 | 10.51 |
P/E ratio | -2.04 x | 60 x | -4.39 x | 2.58 x | -1.46 x | -0.76 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.24 x | 0.25 x | 0.27 x | 0.57 x | 0.39 x | 2.23 x |
EV / Revenue | 0.39 x | 0.42 x | 0.39 x | 0.53 x | 0.51 x | 2.28 x |
EV / EBITDA | -8.77 x | 6.82 x | -488 x | 17.6 x | -2.65 x | -4.9 x |
EV / FCF | -10.5 x | 5.96 x | -2.61 x | 3.55 x | -7.61 x | 6.01 x |
FCF Yield | -9.55% | 16.8% | -38.3% | 28.2% | -13.1% | 16.6% |
Price to Book | 0.74 x | 0.67 x | 0.56 x | 1.08 x | 2.73 x | -20.7 x |
Nbr of stocks (in thousands) | 374,119 | 374,119 | 374,119 | 524,958 | 542,552 | 1,030,848 |
Reference price 2 | 0.0300 | 0.0300 | 0.0230 | 0.0470 | 0.0240 | 0.0100 |
Announcement Date | 4/11/19 | 4/15/20 | 4/13/21 | 4/13/22 | 4/14/23 | 4/12/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 46.86 | 45.46 | 32.23 | 43.03 | 33.79 | 4.613 |
EBITDA 1 | -2.077 | 2.818 | -0.0258 | 1.306 | -6.51 | -2.145 |
EBIT 1 | -4.649 | 0.9148 | -1.501 | -0.0264 | -7.727 | -2.806 |
Operating Margin | -9.92% | 2.01% | -4.66% | -0.06% | -22.87% | -60.82% |
Earnings before Tax (EBT) 1 | -5.532 | 0.1169 | -1.935 | 7.67 | -8.712 | -3.33 |
Net income 1 | -5.488 | 0.2022 | -1.96 | 7.616 | -8.758 | -8.408 |
Net margin | -11.71% | 0.44% | -6.08% | 17.7% | -25.92% | -182.25% |
EPS 2 | -0.0147 | 0.000500 | -0.005238 | 0.0182 | -0.0164 | -0.0131 |
Free Cash Flow 1 | -1.739 | 3.222 | -4.823 | 6.473 | -2.269 | 1.75 |
FCF margin | -3.71% | 7.09% | -14.96% | 15.04% | -6.72% | 37.92% |
FCF Conversion (EBITDA) | - | 114.34% | - | 495.73% | - | - |
FCF Conversion (Net income) | - | 1,593.61% | - | 84.99% | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/11/19 | 4/15/20 | 4/13/21 | 4/13/22 | 4/14/23 | 4/12/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 6.99 | 7.98 | 3.98 | - | 4.24 | 0.2 |
Net Cash position 1 | - | - | - | 1.7 | - | - |
Leverage (Debt/EBITDA) | -3.364 x | 2.833 x | -154.1 x | - | -0.6511 x | -0.0951 x |
Free Cash Flow 1 | -1.74 | 3.22 | -4.82 | 6.47 | -2.27 | 1.75 |
ROE (net income / shareholders' equity) | -30.3% | 1.26% | -12.2% | 40% | -85.6% | -148% |
ROA (Net income/ Total Assets) | -6.32% | 1.34% | -2.16% | -0.04% | -15.5% | -11.6% |
Assets 1 | 86.79 | 15.1 | 90.63 | -20,255 | 56.38 | 72.4 |
Book Value Per Share 2 | 0.0400 | 0.0400 | 0.0400 | 0.0400 | 0.0100 | -0 |
Cash Flow per Share 2 | 0.0100 | 0.0100 | 0.0100 | 0.0200 | 0.0100 | 0 |
Capex 1 | 1.84 | 1.54 | 0.39 | 0.37 | 0.49 | 0.41 |
Capex / Sales | 3.92% | 3.39% | 1.22% | 0.86% | 1.46% | 8.98% |
Announcement Date | 4/11/19 | 4/15/20 | 4/13/21 | 4/13/22 | 4/14/23 | 4/12/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.00% | 8.32M | |
+3.91% | 16.69B | |
+23.07% | 1.79B | |
-12.28% | 1.73B | |
-11.59% | 1.04B | |
-10.54% | 1B | |
-7.32% | 608M | |
-6.71% | 500M | |
-33.77% | 458M | |
-28.34% | 397M |
- Stock Market
- Equities
- 5DX Stock
- Financials Meta Health Limited